Effect of Immunoadsorption Therapy in Patients with Lipoprotein Glomerulopathy

ZHAN Jinfeng,LIU Zhihong,LI Shijun,WANG Qingwen,CHEN Huiping,ZENG Caihong,GONG Dehua,JI Daxi,LI Leishi
DOI: https://doi.org/10.3969/j.issn.1006-298x.2006.03.001
2006-01-01
Abstract:Objective:To evaluate the short-term and long-term effects of immunoadsorption treatment in patients with lipoprotein glomerulopathy (LPG). Methodology:Seventeen patients with biopsy proven LPG were enrolled in this study. They were divided into two groups according to their treatment ways. Eight patients received immunoadsorption on protein A of the staphylococcus bacterium (SPA) plus routine treatment. The other 9 patients received only routine treatment. The levels of proteinuria,serum creatinine,plasma lipid and apoE before and after immunoadsorption treatment were compared. The long-term outcomes between the two groups were analysed. Results: (1) The levels of proteinuria,serum creatinine,plasma lipid and apoE were dramatically decreased (P0.05) after immunoadsorption in all of the 8 patients. Repeated biopsy found the lipoprotein thrombi diminished or even disappeared. (2) The repeated immunoadsorption treatment in patients with relapse after the treatment showed the effective result as same as that of the first treatment,and the remission time has been prolonged in these patients. (3) Follow up data showed that the proteinuria and serum creatinine levels increased slower in patients who received immunoadsorption treatment than in patients of the control group after six-month,one-year and two-year follow-up. The median time that the serum creatinine increased 50 percent was 67 months for the patients who underwent immunoadsorption treatment,while it was 6 months for patients in the control group,but no statistical significance. Conclusion:We demonstrated that the immunoadsorption treatment for LPG did dramatically decrease proteinuria and improve renal function immediately after treatment. By comparing the two groups during the long-term follow-up,we found that the immunoadsorption treatment could protect renal function and delay the progression in patients with LPG.
What problem does this paper attempt to address?